609771-69-9

Upstream product

• 25245-34-5 1-bromo-2,5-dimethoxybenzene 
• 16088-62-3 (S)-Propylene oxide 
• 14293-24-4 1-(2',5'-dimethoxyphenyl)propan-2-one 
• 134040-27-0 2,5-dimethoxy-β-methyl-β-nitrostyrene 
• 93-02-7 2,5-dimethoxybenzaldehyde 

Downstream Products

• 609771-72-4 (2R)-1-(2,5-dimethoxyphenyl)-2-propyl azide 
• 58993-81-0 (-)-DMA 
• 609771-70-2 (2S)-1-(2,5-dimethoxyphenyl)-2-propyl tosylate 

Relevant academic research and scientific papers

Enantioselective Formal Synthesis of the Cytotoxic Topoisomerase II Inhibitor Deoxythysanone, Catalyzed by Chiral Spiroborate Ester

Abstract: Bioactive pyranonaphthoquinone analogs, (1R,3S)-deoxythysanone,(1R,3S)-thysanone, and (1R,3S)-demethoxythysanone can be efficientlysynthesized from a common intermediate product, (S)-3-methyl-3,4-dihydro-1H-isochromene-5,8-dione. We have develop

Organocatalytic approach to (s)-1-arylpropan-2-ols: Enantioselective synthesis of the key intermediate of antiepileptic agent (-)-talampanel

An efficient organocatalytic route for the preparation of enantioselective synthesis of (S)-1-arylpropan-2-ols derivatives, including the key intermediate of antiepileptic agent (-)-talampanel is described. The key steps involved are L-proline-catalyzed a

Stereospecific synthesis of amphetamines

Regioselective addition of aryl lithium to commercially available (S)-(+)-propylene oxide provides the corresponding (S)-aryl-2-propanol. The (R)-amphetamine is obtained by conversion of the alcohol to the tosylate followed by azide displacement and hydrogenation. Mitsunobu conversion of the alcohol to the (R)-bromide followed by azide displacement and hydrogenation affords the (S)-amphetamine.